Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib-Reference-Cited by-同舟云学术

Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib

Published:2014-04-24 Issue:13 Volume:44 Page:1320-1328
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Kawaoka Tomokazu¹,Aikata Hiroshi¹,Kan Hiromi¹,Fujino Hatsue¹,Fukuhara Takayuki¹,Kobayashi Tomoki¹,Naeshiro Noriaki¹,Miyaki Daisuke¹,Hiramatsu Akira¹,Imamura Michio¹,Kawakami Yoshiiku¹,Hyogo Hideyuki¹,Chayama Kazuaki¹

Affiliation:

1. Department of Medicine and Molecular Science, Division of Frontier Medical Science; Hiroshima University; Hiroshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12307/fullpdf

Reference25 articles.

1. Increase in primary liver cancer in the UK, 1979-94;Taylor-Robinson;Lancet,1997

2. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

3. Management of hepatocellular carcinoma in Japan;Okita;J Gastroenterol,2006

4. Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?;Ishii;Jpn J Clin Oncol,2004

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma;Anticancer Research;2023-11

2. Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial;Yonago Acta Medica;2023

3. Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors;Cancers;2022-01-31

4. Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib;Oncology;2020

5. Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease;United European Gastroenterology Journal;2018-03